Grading showed a trend towards metastatic disease in follow-up with 14% in G1, 30% in G2 and 44% in G3 tumors but without statistical significance ( p = 0.0815).
1
—
—
Grading showed a trend towards metastatic disease in follow-up with 14% in G1, 30% in G2 and 44% in G3 tumors but without statistical significance ( p = 0.0815).